CASI Pharmaceuticals, Inc.
CASIF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962738
No open-market purchases or sales by CASI Pharmaceuticals, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $17 in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in CASI Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +2 vs. Q4 2023
- Shares held
- 252.0K
- −23.9K (−8.7%) vs. Q4 2023
- Total value
- $909.6K
- −$1.07M (−54.1%) vs. Q4 2023
- New holders
- 6
- 4 more added
- Sold out
- 4
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASIF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $17 |
| Q1 2026 | 1 | $25 |
| Q4 2025 | 16 | $1.06M |
| Q3 2025 | 22 | $4.33M |
| Q2 2025 | 24 | $2.65M |
| Q1 2025 | 23 | $5.93M |
| Q4 2024 | 22 | $7.52M |
| Q3 2024 | 20 | $8.14M |
| Q2 2024 | 23 | $1.94M |
| Q1 2024 | 20 | $909.6K |
| Q4 2023 | 18 | $1.98M |
| Q3 2023 | 19 | $882.6K |
| Q2 2023 | 19 | $1.12M |
| Q1 2023 | 21 | $2.15M |
| Q4 2022 | 1 | $179 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kozak & Associates, Inc. | 10 | $32 | 0.00% | 00.0% | Unchanged |
| Colonial Trust Co | 11 | $40 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 13 | $47 | 0.00% | 00.0% | Unchanged |
| Mendota Financial Group, LLC | 20 | $73 | 0.00% | +20 | New |
| JPMorgan Chase & Co | 25 | $90 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 40 | $144 | 0.00% | +40 | New |
| Bank of America Corp | 53 | $191 | 0.00% | +50+1,666.7% | Added |
| West Paces Advisors Inc. | 100 | $361 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 300 | $1.03K | 0.00% | +300 | New |
| BlackRock Inc. | 296 | $1.07K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 500 | $1.80K | 0.00% | +500 | New |
| Simplex Trading, LLC | 623 | $2.00K | 0.00% | +570+1,075.5% | Added |
| Morgan Stanley | 1,437 | $5.19K | 0.00% | −16−1.1% | Reduced |
| Catalyst Funds Management Pty Ltd | 1,810 | $6.53K | 0.00% | +1,810 | New |
| Wells Fargo & Company | 12,006 | $43.3K | 0.00% | +12,000+200,000.0% | Added |
| Geode Capital Management, LLC | 22,221 | $80.2K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 36,800 | $133.0K | 0.00% | +7,700+26.5% | Added |
| Howland Capital Management LLC | 40,429 | $145.9K | 0.01% | +40,429 | New |
| Wellington Shields & Co., LLC | 43,091 | $155.6K | 0.05% | 00.0% | Unchanged |
| Wellington Shields Capital Management, LLC | 92,217 | $332.9K | 0.06% | −40,929−30.7% | Reduced |
| Franklin Resources Inc | 0 | $0 | 0.00% | −19,743−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −12,916−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,538−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,222−100.0% | Sold out |